Evaluation of risk factors for vancomycin‐resistant <i><scp>E</scp>nterococcus</i> bacteremia among previously colonized hematopoietic stem cell transplant patients

Abstract

HSCT patients receiving immunosuppressive therapy, who have been exposed to vancomycin subsequent to surveillance culture positivity, have had prolonged neutropenia of >30 days, or first surveillance culture positive at week 1 of admission are potential candidates for early implementation of anti-VRE therapy when a gram-positive bacteremia is suspected.